申请人:NEKTAR THERAPEUTICS
                            
                            
                                公开号:US20140288315A1
                            
                            
                                公开(公告)日:2014-09-25
                            
                            The invention relates to (among other things) oligomer-containing pyrrolidine compounds. A compound of the invention, when administered by any of a number of administration routes, exhibits one or more advantages over corresponding compounds lacking the oligomer.